On-demand webinar: Pyrogenic Risk in Pharma Process Webinar – from bioburden to pyrogens
Microbial risk in pharmaceutical process is not limited to living microorganisms and intact microbial cells.
List view / Grid view
Microbial risk in pharmaceutical process is not limited to living microorganisms and intact microbial cells.
High-resolution measurements of particles are of great interest in many fields of application. Combining confocal Raman microscopy with particle analysis tools makes it possible to find, classify and identify particles almost entirely automatically.
ADVANCES in biotherapeutics are generating an increasing range of complex molecules that present unique and often complex purification challenges.
The practice of bottom-up proteomics relies to a large extent on the separation performance that can be achieved with state-of-the art nano LC-MS/MS equipment.
To ensure that USP/EP standards are met, TOC of highly purified water can be determined by internal purification-process monitoring.
Antibody-drug conjugates (ADC) represent a rapidly emerging class of biotherapeutic molecules, which harness the specificity of monoclonal antibodies (mAb) to selectively deliver highly potent cytotoxic drugs. Like all biotherapeutics they require significant analytical characterization.
Analytical techniques for QA/QC purposes are integral to the safe production of therapeutics. This in-depth focus looks at Raman spectroscopy for amorphous phase analysis and discusses the viable but non-culturable (VBNC) state of bacteria in environmental monitoring.
HPLC is critical to the discovery, development and eventual commercialization of pharmaceutical products. HPLC is the benchmark analytical method in the pharmaceutical industry due to its ability to score such high marks in analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
The process of manufacturing a biotherapeutic drug entails numerous quality control measures to ensure safety and efficacy. The articles in this in-depth focus discuss higher order structure analysis and host cell protein contamination issues.
Introduced at ASMS 2019, the new SYNAPT XS provides ultimate flexibility offering greater freedom of analytical choice to support scientific creativity and technical success for any application.
The latest research and developments from Pharma and Biopharma industry experts.
Light Scattering of macromolecules in solution has seen increasing interest over the past decades from scientists studying polymers and proteins.
Metallic contamination in drug products, referred to as elemental impurities, may arise from several sources.
Our culture media are the reliable and convenient choice for aseptic process simulation and include Ready-to-use and Dehydrated Culture Media to meet the specific needs in the pharmaceutical industry.
Generic screening to provide fast solutions for chiral method development, whether needed for routine analytical use, trace analysis, LC/MS or preparative LC, has become increasingly important.